比高(08220.HK)廣州設合營 增強現實數字真人角色扮演遊戲項目
比高集團(08220.HK)公佈,與廣州玖的文化科技訂立框架協議,成立一間合營公司 以開展有關發展增強現實數字真人角色扮演遊戲(LARP)項目。
合營公司設於廣州,分別由比高及廣州玖的文化科技分別擁有51%及49%。
比高稱,近年LARP遊戲已成爲中國消費者最受歡 迎的娛樂方式之一,而廣州玖的文化科技一家經 驗豐富的LARP項目開發者,或其聯營公司運行着 名的LARP平臺「玖號房」,是中國較爲完善的LARP遊戲系統,故將是公司進軍LARP市場以及熱門增強現實與虛擬現實應用業務之機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.